Log in

NYSEARCA:XPHSPDR S&P Pharmaceuticals ETF Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $43.33
50-Day Range
MA: $42.98
52-Week Range
Now: $43.33
Volume26,100 shs
Average Volume119,965 shs
Market Capitalization$236.15 million
P/E RatioN/A
Dividend Yield0.68%
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.
Read More

Geographic Exposure of XPH

Currency Exposure of XPH

Sector Exposure of XPH

Industry Exposure of XPH

Basic Details

Issuer SSgA
Fund NameSPDR S&P Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
Inception Date6/19/2006
Fund ManagerMichael Feehily, Karl Schneider, Keith Richardson

Fund Focus

Asset ClassEquity
BenchmarkS&P Pharmaceuticals Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$236.21 million
Average Daily Volume$120,945.50

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSGA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Lead Market MakerCredit Suisse

Receive XPH News and Ratings via Email

Sign-up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter.

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Frequently Asked Questions

How has SPDR S&P Pharmaceuticals ETF's stock been impacted by COVID-19 (Coronavirus)?

SPDR S&P Pharmaceuticals ETF's stock was trading at $37.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, XPH shares have increased by 15.8% and is now trading at $43.33. View which stocks have been most impacted by Coronavirus.

How often does SPDR S&P Pharmaceuticals ETF pay dividends? What is the dividend yield for SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF declared a quarterly dividend on Monday, December 23rd. Stockholders of record on Tuesday, December 24th will be paid a dividend of $0.0711 per share on Friday, December 27th. This represents a $0.28 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Monday, December 23rd. This is an increase from SPDR S&P Pharmaceuticals ETF's previous quarterly dividend of $0.07. View SPDR S&P Pharmaceuticals ETF's dividend history.

Has SPDR S&P Pharmaceuticals ETF been receiving favorable news coverage?

News headlines about XPH stock have been trending neutral this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SPDR S&P Pharmaceuticals ETF earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about SPDR S&P Pharmaceuticals ETF.

What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE), Bank of America (BAC), Target (TGT), Broadcom (AVGO), ConocoPhillips (COP), Chevron (CVX), Docusign (DOCU), SPDR Gold Shares (GLD), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Who are SPDR S&P Pharmaceuticals ETF's key executives?

SPDR S&P Pharmaceuticals ETF's management team includes the following people:
  • James E. Ross, President, Trustee (Age 52)
  • Peter A. Ambrosini, Chief Compliance Officer (Age 69)
  • Michael P. Riley, Vice President (Age 44)
  • Gary L. French, Treasurer (Age 64)
  • John W. Clark, Assistant Treasurer (Age 46)
  • Matthew W. Flaherty, Assistant Treasurer (Age 42)
  • Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
  • Mary Moran Zeven, Secretary (Age 52)
  • Scott M. Zoltowski, Assistant Secretary (Age 44)
  • Dave Kelly, Independent Trustee

What is SPDR S&P Pharmaceuticals ETF's stock symbol?

SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XPH."

Who are SPDR S&P Pharmaceuticals ETF's major shareholders?

SPDR S&P Pharmaceuticals ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.78%).

Which institutional investors are buying SPDR S&P Pharmaceuticals ETF stock?

XPH stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc..

How do I buy shares of SPDR S&P Pharmaceuticals ETF?

Shares of XPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SPDR S&P Pharmaceuticals ETF's stock price today?

One share of XPH stock can currently be purchased for approximately $43.33.

How big of a company is SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF has a market capitalization of $236.15 million.

What is SPDR S&P Pharmaceuticals ETF's official website?

The official website for SPDR S&P Pharmaceuticals ETF is www.spdrs.com.

How can I contact SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF's mailing address is State Street Financial Center One Lincoln Street, BOSTON, MA 02111, United States. The company can be reached via phone at +1-617-6644738.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.